Donald Reeves III Sells 277 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP Donald Reeves III sold 277 shares of the stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $22,049.20. Following the transaction, the senior vice president owned 29,674 shares of the company’s stock, valued at $2,362,050.40. The trade was a 0.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Performance

Shares of ITRI opened at $83.02 on Friday. Itron, Inc. has a 12 month low of $77.77 and a 12 month high of $142.00. The firm has a fifty day simple moving average of $88.45 and a 200 day simple moving average of $94.52. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 13.24, a PEG ratio of 0.72 and a beta of 1.35. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same quarter in the prior year, the company posted $1.52 earnings per share. The firm’s revenue was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Research analysts forecast that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ITRI. Raymond James Financial began coverage on shares of Itron in a report on Tuesday, April 21st. They set an “underperform” rating for the company. Robert W. Baird set a $128.00 target price on shares of Itron and gave the stock an “outperform” rating in a report on Wednesday, February 18th. Needham & Company LLC began coverage on shares of Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 target price for the company. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Finally, Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Institutional Trading of Itron

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. Impax Asset Management Group plc raised its position in Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after acquiring an additional 890,040 shares in the last quarter. Norges Bank bought a new stake in Itron during the fourth quarter worth $63,990,000. Soros Fund Management LLC bought a new stake in Itron during the fourth quarter worth $34,843,000. Millennium Management LLC raised its position in Itron by 269.3% during the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock worth $47,068,000 after acquiring an additional 369,617 shares in the last quarter. Finally, Merewether Investment Management LP raised its position in Itron by 1,552.7% during the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after acquiring an additional 282,587 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.